Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001140361-21-006735

SVP, Chief Commercial Officer acquired 16,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wessels Gregory S. SVP, Chief Commercial Officer 2021-02-25 Grant or award +16,000 16,000 D
Derivatives
Wessels Gregory S. SVP, Chief Commercial Officer 2021-02-25 Grant or award · Stock Option (right to Buy) +66,000 66,000 D
Loading xslF345X03/form4.xml…